nystatin-a1 has been researched along with Leukoplakia--Hairy* in 2 studies
2 other study(ies) available for nystatin-a1 and Leukoplakia--Hairy
Article | Year |
---|---|
Iatrogenic oral hairy leukoplakia: report of two cases.
Oral hairy leukoplakia (OHL) presents as a white, plaque-like lesion typically occurring on the lateral border of the tongue. This condition is caused by the Epstein-Barr virus, a human herpesvirus that often establishes lifelong, asymptomatic latent infection. OHL, initially described in immunocompromised men infected with the human immunodeficiency virus (HIV), has also been described in other severely immunocompromised patients. Only rarely has OHL been reported in less profoundly immunocompromised patients primarily in the setting of corticosteroid therapy. Here we report on two additional cases of OHL attributable to immunosuppressive medications. Topics: Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Antifungal Agents; Arthritis, Rheumatoid; Clobetasol; Dapsone; Dermatologic Agents; Dexamethasone; Diabetes Mellitus, Type 2; Epstein-Barr Virus Infections; Female; Fluconazole; Humans; Immunocompromised Host; Leukoplakia, Hairy; Lichen Planus; Methotrexate; Nystatin; Prednisone; Zinc Oxide | 2011 |
Oral hairy leukoplakia in a HIV-negative asthmatic patient on systemic steroids.
Topics: Antifungal Agents; Asthma; Betamethasone; Candidiasis, Oral; HIV Seronegativity; Humans; Ketoconazole; Leukoplakia, Hairy; Male; Middle Aged; Nystatin | 1995 |